Faculty of Health Sciences and Medicine, Bond University, Queensland, Australia.
Gold Coast Hospital and Health Service, Queensland, Australia.
Maturitas. 2019 Dec;130:57-67. doi: 10.1016/j.maturitas.2019.10.006. Epub 2019 Oct 12.
Dietary fibre and probiotics may play a role in the management of diverticular disease. This systematic review synthesises the evidence on the effects of dietary fibre modifications, with or without the use of probiotics, on the incidence in older adults of asymptomatic (AS) or symptomatic uncomplicated diverticular disease (SUDD), as well as on gastrointestinal function and symptoms. Five electronic databases were searched for studies through to December 2018. The body of evidence was appraised using the Cochrane Risk of Bias tool and GRADE. Nine studies were included, with mean sample ages ranging from 57 to 70 years, and three meta-analyses were performed. Only one study, with high risk of bias, measured the effect of dietary fibre on the incidence of diverticulitis. Dietary fibre supplementation improved stool weight (MD: 42 g/day, P < 0.00001; GRADE level of evidence: low), but had no significant effect on gastrointestinal symptoms (SMD: -0.13, P = 0.16; GRADE level of evidence: low) or stool transit time (MD: -3.70, P = 0.32 GRADE level of evidence: low). There was "very low" confidence for the body of evidence supporting symbiotics for AS or SUDD. A high dietary fibre intake, in line with dietary guidelines, may improve gastrointestinal function and is recommended in patients with AS or SUDD. Dietary fibre supplementation should be considered on an individualised basis to improve bowel function, while any recommendation on symbiotic supplements requires further well-designed research. Future studies should also measure the impact on the incidence of diverticulitis.
膳食纤维和益生菌可能在憩室病的治疗中发挥作用。本系统综述综合了膳食纤维改变(包括使用和不使用益生菌)对无症状(AS)或有症状但不复杂的憩室病(SUDD)发病率的影响,以及对胃肠道功能和症状的影响的证据。通过电子数据库检索了截至 2018 年 12 月的研究。使用 Cochrane 偏倚风险工具和 GRADE 评估证据体。共纳入 9 项研究,平均样本年龄为 57 至 70 岁,进行了 3 项荟萃分析。只有一项研究存在高偏倚风险,测量了膳食纤维对憩室炎发病率的影响。膳食纤维补充剂可改善粪便重量(MD:42g/天,P<0.00001;GRADE 证据水平:低),但对胃肠道症状(SMD:-0.13,P=0.16;GRADE 证据水平:低)或粪便转运时间(MD:-3.70,P=0.32;GRADE 证据水平:低)没有显著影响。支持 AS 或 SUDD 使用共生体的证据体的置信度“非常低”。按照饮食指南摄入高膳食纤维可能会改善胃肠道功能,建议 AS 或 SUDD 患者摄入。膳食纤维补充剂应根据个人情况考虑以改善肠道功能,而关于共生体补充剂的任何建议都需要进一步进行精心设计的研究。未来的研究还应测量对憩室炎发病率的影响。